Literature DB >> 4972918

Locus of the action of serum and the role of lysozyme in the serum bactericidal reaction.

D S Feingold, J N Goldman, H M Kuritz.   

Abstract

The mechanism of the lethal action of human serum on a rough strain of Escherichia coli was investigated by use of serum with and without lysozyme, in medium of low and high osmotic pressure, with cells radioactively labeled in the peptidoglycan polymer, and by electron microscopy. The results suggested that there are two separate components in the bacterial cell wall that afford structural support for the cell. Lysozyme attacked one of these, the peptidoglycan polymer. Serum damaged the other, which is probably the peripherally located lipopolysaccharide-phospholipid complex. The cell wall damage caused by lysozyme-free serum promptly resulted in cell death under usual conditions. In plasmolyzed cells, however, the wall damage was not lethal, presumably because the membrane of the plasmolyzed cell was protected from secondary lethal changes which otherwise occur.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4972918      PMCID: PMC252565          DOI: 10.1128/jb.96.6.2118-2126.1968

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  23 in total

1.  Locus of the lethal event in the serum bactericidal reaction.

Authors:  D S Feingold; J N Goldman; H M Kuritz
Journal:  J Bacteriol       Date:  1968-12       Impact factor: 3.490

2.  Lysozyme sensitivity of the cell wall of Pseudomonas aeruginosa. Further evidence for the role of the non-peptidoglycan components in cell wall rigidity.

Authors:  K J Carson; R G Eagon
Journal:  Can J Microbiol       Date:  1966-02       Impact factor: 2.419

3.  Osmotic stability of bacterial protoplasts related to molecular size of stabilizing solutes.

Authors:  R E Marquis
Journal:  Biochem Biophys Res Commun       Date:  1965-09-08       Impact factor: 3.575

4.  A kinetic study of the bacteriolytic and bactericidal action of human serum.

Authors:  A A Glynn; C M Milne
Journal:  Immunology       Date:  1967-06       Impact factor: 7.397

5.  An extracellular lipopolysaccharide-phospholipid-protein complex produced by Escherichia coli grown under lysine-limiting conditions.

Authors:  K W Knox; J Cullen; E Work
Journal:  Biochem J       Date:  1967-04       Impact factor: 3.857

6.  Lysis of Vibrio succinogenes by ethylenediamine-tetraacetic acid or lysozyme.

Authors:  M J Wolin
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

7.  Lysis of Escherichia coli by ethylenediaminetetraacetate and phospholipases as measured by beta-galactosidase activity.

Authors:  M W Slein; G F Logan
Journal:  J Bacteriol       Date:  1967-10       Impact factor: 3.490

8.  Enzyme-induced formation of spheres from cells and envelopes of Escherichia coli.

Authors:  G Weinbaum; R Rich; D A Fischman
Journal:  J Bacteriol       Date:  1967-05       Impact factor: 3.490

9.  Production and ultrastructure of lysozyme and ethylenediaminetetraacetate-lysozyme spheroplasts of Escherichia coli.

Authors:  D C Birdsell; E H Cota-Robles
Journal:  J Bacteriol       Date:  1967-01       Impact factor: 3.490

10.  Reassociation of purified lipopolysaccharide and phospholipid of the bacterial cell envelope: electron microscopic and monolayer studies.

Authors:  L Rothfield; R W Horne
Journal:  J Bacteriol       Date:  1967-05       Impact factor: 3.490

View more
  36 in total

1.  Pseudomonas aeruginosa Psl polysaccharide reduces neutrophil phagocytosis and the oxidative response by limiting complement-mediated opsonization.

Authors:  Meenu Mishra; Matthew S Byrd; Susan Sergeant; Abul K Azad; Matthew R Parsek; Linda McPhail; Larry S Schlesinger; Daniel J Wozniak
Journal:  Cell Microbiol       Date:  2011-11-10       Impact factor: 3.715

2.  Determinants of activation by complement of group II phospholipase A2 acting against Escherichia coli.

Authors:  L M Madsen; M Inada; J Weiss
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Listeria monocytogenes is resistant to lysozyme through the regulation, not the acquisition, of cell wall-modifying enzymes.

Authors:  Thomas P Burke; Anastasia Loukitcheva; Jason Zemansky; Richard Wheeler; Ivo G Boneca; Daniel A Portnoy
Journal:  J Bacteriol       Date:  2014-08-25       Impact factor: 3.490

4.  Interaction of Gram-Negative Bacteria with the Lysosomal Fraction of Polymorphonuclear Leukocytes I. Role of Cell Wall Composition of Salmonella typhimurium.

Authors:  D Friedberg; M Shilo
Journal:  Infect Immun       Date:  1970-03       Impact factor: 3.441

5.  The effect of leukocyte hydrolases on bacteria : IV. The role played by artificial enzyme "cocktails" and tissue enzymes in bacteriolysis.

Authors:  I Ginsburg; N Neeman; Z Duchan; M N Sela; J James; M Lahav
Journal:  Inflammation       Date:  1975-03       Impact factor: 4.092

6.  Resistance of Escherichia coli to osmotically introduced complement component C9.

Authors:  J R Dankert
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

7.  Multimeric complement component C9 is necessary for killing of Escherichia coli J5 by terminal attack complex C5b-9.

Authors:  K A Joiner; M A Schmetz; M E Sanders; T G Murray; C H Hammer; R Dourmashkin; M M Frank
Journal:  Proc Natl Acad Sci U S A       Date:  1985-07       Impact factor: 11.205

8.  Killing of Gram-negative bacteria with normal human serum and normal bovine serum: use of lysozyme and complement proteins in the death of Salmonella strains O48.

Authors:  G Bugla-Płoskońska; A Kiersnowski; B Futoma-Kołoch; W Doroszkiewicz
Journal:  Microb Ecol       Date:  2009-03-18       Impact factor: 4.552

9.  Effects of phagocytosis by rabbit granulocytes on macromolecular synthesis and degradation in different species of bacteria.

Authors:  P Elsbach; P Pettis; S Beckerdite; R Franson
Journal:  J Bacteriol       Date:  1973-08       Impact factor: 3.490

10.  Formation of transmural complement pores in serum-sensitive Escherichia coli.

Authors:  S Bhakdi; G Kuller; M Muhly; S Fromm; G Seibert; J Parrisius
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.